The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients

Sponsor
Far Eastern Memorial Hospital
Study ID
NCT07385976
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Accepted

Interventions

  • Doppler ultrasound — DIAGNOSTIC_TEST
    3D doppler ultrasound to measure VI, FI, VFI.

Study Details

This study will elucidate the role of 3D transvaginal ultrasound in assessing (1) cervical vascularity and blood flow in patients with cervical cancer and cervical intraepithelial neoplasm, and (2) tumor vascularity and blood flow in patients with ovarian cancer.

Key Dates

First listed
Feb 4, 2026
Start date
Jan 19, 2026
Status verified
Jan 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: cervical cancer
    cervical cancer patients
  • Arm: cervical intraepithelial neoplasm
    cervical intraepithelial neoplasm patients
  • Arm: control
    Gynecological patients without cervical disease
  • Arm: ovarian cancer
    ovarian cancer patients

Primary Outcome Measure

Vascularization-flow index [ Time Frame: 3 years ]

Find similar trials

Nationwide
Cervical cancer trialsOvarian cancer trialsOncology trialsGynecologic oncology trialsWomen's health trials

Related Studies